U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
REHOVOT, Israel, April 26, 2017 -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company for the improvement of crop productivity, announced today that it will release its financial results for the first quarter of 2017 on Wednesday, May 17, 2017.
On the day of the announcement, the Company’s management will host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. To access the conference call, please dial 1-888-668-9141 toll free from the United States, or +972-3-918-0610 internationally. Access to the call will also be available via live webcast through the Company’s website at www.evogene.com.
A replay of the conference call will be available approximately three hours following the completion of the call. To access the replay, please dial 1-888-295-2634 toll free from the United States, or +972-3-925-5937 internationally. The replay will be accessible through May 19, 2017, and an archive of the webcast will be available on the Company’s website through May 28, 2017.
About Evogene Ltd.:
Evogene (NASDAQ:EVGN) (TASE:EVGN) is a leading biotechnology company for the improvement of crop productivity for the food, feed and fuel industries. The Company operates in three key market segments: improved seed traits (addressing yield and resistance to diseases and environmental stresses); innovative ag-chemicals (developing novel herbicide solutions for weed control); and ag-biologicals. Evogene has collaborations with world-leading seed and ag-chemical companies. For more information, please visit www.evogene.com or contact the Company at [email protected].
This press release contains "forward-looking statements" relating to future events. These statements may be identified by words such as "may", "could", “expects”, "intends", “anticipates”, “plans”, “believes”, “scheduled”, “estimates” or words of similar meaning. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Evogene may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which beyond Evogene's control, including, without limitation, those risk factors contained in Evogene’s reports filed with the appropriate securities authority. Evogene disclaims any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.
Contact: Alex Tasker Chief Financial Officer E: [email protected] T: (+972)-8-931-1963
